|
1.
|
Nielsen S, Frør J and Knepper MA: Renal
aquaporins: key roles in water balance and water balance disorders.
Curr Opin Nephrol Hypertens. 7:509–516. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Nielsen S, Kwon TH, Christensen BM,
Promeneur D, Frøkiaer J and Marples D: Physiology and
pathophysiology of renal aqua-porins. J Am Soc Nephrol. 10:647–663.
1999.
|
|
3.
|
Huang JH, Xie LD, Jiang DW, et al: Effect
of vasopressin on the expression of aquaporin 2 in kidney in WKY
rats. Chin J Hypertens. 16:427–430. 2008.(In Chinese).
|
|
4.
|
Ou YS, Chen W and Kuang XB: Effect of
urinary aquaporin-2 in low renin essential hypertension. Chin J
Cardiovasc Rev. 6:55–58. 2008.(In Chinese).
|
|
5.
|
Matsukawa T and Miyamoto T: Angiotensin
II-stimulated secretion of arginine vasopressin is inhibited by
atrial natriuretic peptide in humans. Am J Physiol Regul Integr
Comp Physiol. 300:R624–R629. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Erdös EG: Conversion of angiotensin I to
angiotensin II. Am J Med. 60:749–759. 1976.
|
|
7.
|
Hosoya K and Ishimitsu T: Protection of
the cardiovascular system by imidapril, a versatile
angiotensin-converting enzyme inhibitor. Cardiovasc Drug Rev.
20:93–110. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Wong NL and Tsui JK: Upregulation of
vasopressin V2 and aquaporin 2 in the inner medullary collecting
duct of cardiomyopathic hamsters is attenuated by enalapril
treatment. Metabolism. 51:970–975. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Jiang RY, Xu DL, Lai WY, et al:
Quantitative measurement of urinary excretion of aquaporin-2 water
channel protein in rat by indirect ELISA. Chin J Geriat Heart Brain
Vessel Dis. 7:260–262. 2005.(In Chinese).
|
|
10.
|
Lu W, Xu D and Yin X: Development of
double antibody sandwich ELISA assay in detection of urinary
aquaporin-2 concentration. Journal of First Military Medical
University. 22:486–489. 2002.
|
|
11.
|
Hasler U, Mordasini D, Bens M, Bens M,
Bianchi M, Cluzeaud F, Rousselot M, Vandewalle A, Feraille E and
Martin PY: Long term regulation of aquaporin-2 expression in
vasopressin-responsive renal collecting duct principal cells. J
Biol Chem. 277:10379–10386. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Deen PM, van Balkom BW and Kamsteeg EJ:
Routing of the aquaporin-2 water channel in health and disease. Eur
J Cell Biol. 79:523–530. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Zhu TY, Gu Y, Huang GY, et al: Expression
of channel protein mRNA in kidney of congestive heart failure and
its significance. Chin J Nephrol. 18:438–441. 2002.(In
Chinese).
|
|
14.
|
Earm JH, Christensen BM, Frøkiaer J,
Marples D, Han JS, Knepper MA and Nielsen S: Decreased aquaporin-2
expression and apical plasma membrane delivery in kidney collecting
ducts of polyuric hypercalcemic rats. J Am Soc Nephrol.
9:2181–2193. 1998.PubMed/NCBI
|
|
15.
|
Pedersen RS, Bentzen H, Bech JN and
Pedersen EB: Effect of an acute oral lithium intake on urinary
aquaporin-2 in healthy humans with and without simultaneous
stimulation with hypertonic saline infusion. Scand J Clin Lab
Invest. 63:181–194. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Weir MR and Dzau VJ: The
renin-angiotensin-aldosterone system: a specific target for
hypertension management. Am J Hypertens. 12:205S–213S. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Sigmund CD: Divergent mechanism regulation
fluid intake and metabolism by the brain renin-angiotensin system.
Am J Physiol Integr Comp Physiol. 302:313–320. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Kon Y: Comparative study of
renin-containing cells: histological approaches. J Vet Med Sci.
61:1075–1086. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Mesquita FF, Gontijo JA and Boer PA:
Expression of renin-angiotensin system signaling compounds in
material protein-restricted rates: effects on renal sodium
excretion and blood pressure. Nephrol Dial Transplant. 25:380–388.
2012. View Article : Google Scholar
|
|
20.
|
Song JC and White CM: Clinical
pharmacokinetics and selective pharmacodynamics of new angiotensin
converting enzyme inhibitors: an update. Clin Pharmacokinet.
41:207–224. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Guo XG, Uzui H, Mizuguchi T, Ueda T, Chen
JZ and Lee JD: Imidaprilat inhibits matrix metalloproteinase-2
activity in human cardiac fibroblasts induced by interleukin-1beta
via NO-dependent pathway. Int J Cardiol. 126:414–420. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Naitoh M, Suzuki H, Arakawa K, et al: Role
of kinin and renal AngII blockade in acute effects of ACE
inhibitors in low-renin hypertension. Am J Physiol. 272:H679–H687.
1997.PubMed/NCBI
|
